NEW YORK – Utah Science Technology and Research Initiative (USTAR) spinout Eigengene has developed a proprietary mathematical approach to discover patterns in cancer whole-genome sequencing data. Headquartered in Palo Alto, California, the firm believes it can use its technique to build clinically actionable genetic signatures in a wide variety of cancers for personalized prognostic, companion diagnostic, and therapeutic purposes.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.